For 50 years, Cordis Corporation, a Johnson & Johnson company, has pioneered less invasive treatments for vascular disease. Technological innovation and a deep understanding of the medical marketplace and the needs of patients have made Cordis the world's leading developer and manufacturer of breakthrough stents, catheters and guidewires for interventional medicine, minimally invasive computer-based imaging, and electrophysiology.
Today, approximately 5,000 Cordis employees worldwide share a strong commitment to continue the Company's groundbreaking work in the fight against vascular disease.
Business Units/Subsidiaries: Cordis is focused in five distinct areas:
430 Route 22 East
Bridgewater, NJ 08807
If you are a reporter or member of the news media and have questions about Cordis Corporation, Biosense Webster or Biologics Delivery Systems Group, please contact Cordis Corporate Communications at 732-524-3388 or by email at CordisMediaRelations@its.jnj.com
If you are a patient please contact our Customer Service Department, Monday – Friday, 8:30AM - 9:00PM (Eastern Standard Time). Outside of normal hours of operation, there is an answering service, and calls will be returned the following business day.
Phone: (800) 327-7714, Fax: (800) 997-1122
If you are a financial analyst, please visit the Johnson & Johnson Web site Investor Relations section at http://www.investor.jnj.com/investor-relations.cfm or call 1-800-950-5089.
Web Site Address: http://www.cordis.com